On 2025-05-12, Tango Therapeutics, Inc. (TNGX) announced earnings per share of $-0.36 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.34.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.36 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.34 | $-0.36 |
| 2025-02-27 | 2024-12-31 | $-0.32 | $-0.35 |
| 2024-11-06 | 2024-09-30 | $-0.34 | $-0.27 |
| 2024-08-07 | 2024-06-30 | $-0.34 | $-0.24 |
| 2024-05-08 | 2024-03-31 | $-0.31 | $-0.35 |
| 2024-03-18 | 2023-12-31 | $-0.28 | $-0.32 |
| 2023-11-08 | 2023-09-30 | $-0.34 | $-0.23 |
| 2023-08-07 | 2023-06-30 | $-0.35 | $-0.23 |
| 2023-05-09 | 2023-03-31 | $-0.36 | $-0.32 |
| 2023-03-27 | 2022-12-31 | $-0.36 | $-0.33 |
| 2022-11-10 | 2022-09-30 | $-0.32 | $-0.33 |
| 2022-08-10 | 2022-06-30 | $-0.33 | $-0.28 |
| 2022-05-11 | 2022-03-31 | $-0.28 | $-0.29 |
| 2022-03-28 | 2021-12-31 | $-0.28 | $-0.25 |
| 2021-11-09 | 2021-09-30 | $-0.26 | $-0.28 |